MDWD
HEALTHCAREMediWound Ltd
$17.37-0.07 (-0.40%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving MDWD Today?
No stock-specific AI insight has been generated for MDWD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$14.90$22.50
$17.37
Fundamentals
Market Cap$223M
P/E Ratio—
EPS$-2.10
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin-1.4%
Debt / Equity—
Trading
Volume64K
Avg Volume (10D)—
Shares Outstanding12.9M
MDWD News
20 articles- Profound Medical (PROF) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- MediWound to Report First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound DebridementYahoo Finance·Apr 13, 2026
- MediWound to Present New EscharEx® Data at Leading Wound Care ConferencesGlobeNewswire Inc.·Apr 7, 2026
- MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 MillionYahoo Finance·Apr 2, 2026
- MediWound Q4 Earnings Call HighlightsMarketbeat·Mar 6, 2026
- MediWound Files Annual Report on Form 20-FYahoo Finance·Mar 5, 2026
- MediWound Ltd. Q4 2025 Earnings Call SummaryMoby·Mar 5, 2026
- MediWound (MDWD) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 5, 2026
- MediWound (MDWD) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 5, 2026
- MediWound: Q4 Earnings SnapshotYahoo Finance·Mar 5, 2026
- MediWound Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 5, 2026
- MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer ConferenceMarketbeat·Mar 1, 2026
- MediWound to Report Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 19, 2026
- MediWound to Present at Upcoming Investor ConferencesYahoo Finance·Feb 17, 2026
- MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare ConferenceYahoo Finance·Jan 12, 2026
- MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52%Yahoo Finance·Dec 19, 2025
- MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast InjuriesYahoo Finance·Dec 10, 2025
- MediWound (NASDAQ:MDWD) Is In A Good Position To Deliver On Growth PlansYahoo Finance·Nov 22, 2025
- MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions ...Yahoo Finance·Nov 20, 2025
All 20 articles loaded
Price Data
Open$17.26
Previous Close$17.44
Day High$17.55
Day Low$17.13
52 Week High$22.50
52 Week Low$14.90
52-Week Range
$14.90$22.50
$17.37
Fundamentals
Market Cap$223M
P/E Ratio—
EPS$-2.10
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin-1.4%
Debt / Equity—
Trading
Volume64K
Avg Volume (10D)—
Shares Outstanding12.9M
About MediWound Ltd
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—